Genetic Predisposition of Anti-Cytomegalovirus Immunoglobulin G Levels and the Risk of 9 Cardiovascular Diseases

被引:22
作者
Tan, Jiang-Shan [1 ]
Ren, Jia-Meng [2 ,6 ]
Fan, Luyun [3 ]
Wei, Yuhao [4 ]
Hu, Song [5 ]
Zhu, Sheng-Song [5 ]
Yang, Yanmin [1 ]
Cai, Jun [3 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Emergency Ctr, Natl Ctr Cardiovasc Dis,Natl Clin Res Ctr Cardiova, Beijing, Peoples R China
[2] Peking Univ Third Hosp, Inst Vasc Med, NHC Key Lab Cardiovasc Mol Biol & Regulatory Pepti, Key Lab Mol Cardiovasc Sci,Minist Educ,Beijing Key, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Hypertens Ctr, State Key Lab Cardiovasc Dis,Natl Ctr Cardiovasc D, Beijing, Peoples R China
[4] Peking Univ, China Japan Friendship Sch Clin Med, Beijing, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Ctr Resp & Pulm Vasc Dis, Dept Cardiol,Key Lab Pulm Vasc Med,Natl Clin Res C, Beijing, Peoples R China
[6] Peking Univ Third Hosp, Dept Cardiol, NHC Key Lab Cardiovasc Mol Biol & Regulatory Pepti, Key Lab Mol Cardiovasc Sci,Minist Educ,Beijing Key, Beijing, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
cytomegalovirus; cardiovascular disease; Mendelian randomization; immunology; risk; CORONARY-HEART-DISEASE; ACUTE CYTOMEGALOVIRUS-INFECTION; MENDELIAN RANDOMIZATION; VENOUS THROMBOEMBOLISM; CHLAMYDIA-PNEUMONIAE; HELICOBACTER-PYLORI; VEIN-THROMBOSIS; RARE VARIANTS; T-CELLS; ATHEROSCLEROSIS;
D O I
10.3389/fcimb.2022.884298
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundAccumulating evidence has indicated that persistent human cytomegalovirus (HCMV) infection is associated with several cardiovascular diseases including atherosclerosis and coronary artery disease. However, whether there is a causal association between the level of anti-HCMV immune response and the risk of cardiovascular diseases remains unknown. MethodsSingle-nucleotide polymorphisms associated with anti-cytomegalovirus immunoglobulin (Ig) G levels were used as instrumental variables to estimate the causal effect of anti-cytomegalovirus IgG levels on 9 cardiovascular diseases (including atrial fibrillation, coronary artery disease, hypertension, heart failure, peripheral artery disease, pulmonary embolism, deep vein thrombosis of the lower extremities, rheumatic valve diseases, and non-rheumatic valve diseases). For each cardiovascular disease, Mendelian randomization (MR) analyses were performed. Inverse variance-weighted meta-analysis (IVW) with a random-effects model was used as a principal analysis. In addition to this, the weighted median approach and MR-Egger method were used for further sensitivity analysis. ResultsIn the IVW analysis, genetically predicted anti-cytomegalovirus IgG levels were suggestively associated with coronary artery disease with an odds ratio (OR) of 1.076 [95% CI, 1.009-1.147; p = 0.025], peripheral artery disease (OR 1.709; 95% CI, 1.039-2.812; p = 0.035), and deep vein thrombosis (OR 1.002; 95% CI, 1.000-1.004; p = 0.025). In the further analysis, similar causal associations were obtained from weighted median analysis and MR-Egger analysis with lower precision. No notable heterogeneities and horizontal pleiotropies were observed (p > 0.05). Conclusions/InterpretationOur findings first provide direct evidence that genetic predisposition of anti-cytomegalovirus IgG levels increases the risk of coronary artery disease, peripheral artery disease, and deep vein thrombosis.
引用
收藏
页数:9
相关论文
共 70 条
  • [1] Microbiome, inflammation, epigenetic alterations, and mental diseases
    Alam, Reza
    Abdolmaleky, Hamid M.
    Zhou, Jin-Rong
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2017, 174 (06) : 651 - 660
  • [2] Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients A Phase 2, Randomized Clinical Trial
    Aldoss, Ibrahim
    La Rosa, Corinna
    Baden, Lindsey R.
    Longmate, Jeffrey
    Ariza-Heredia, Ella J.
    Rida, Wasima N.
    Lingaraju, Chetan Raj
    Zhou, Qiao
    Martinez, Joy
    Kaltcheva, Teodora
    Dagis, Andy
    Hardwick, Nicola
    Issa, Nicolas C.
    Farol, Len
    Nademanee, Auayporn
    Al Malki, Monzr M.
    Forman, Stephen
    Nakamura, Ryotaro
    Diamond, Don J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (05) : 306 - +
  • [3] Incidence of Cytomegalovirus-associated thrombosis and its risk factors: A case-control study
    Atzmony, Lihi
    Halutz, Ora
    Avidor, Boaz
    Finn, Talya
    Zimmerman, Ofer
    Steinvil, Arie
    Zeltser, David
    Giladi, Michael
    Justo, Dan
    [J]. THROMBOSIS RESEARCH, 2010, 126 (06) : E439 - E443
  • [4] Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988-2004
    Bate, Sheri Lewis
    Dollard, Sheila C.
    Cannon, Michael J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (11) : 1439 - 1447
  • [5] Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women
    Bloemenkamp, DGM
    Mali, WPTM
    Tanis, BC
    Rosendaal, FR
    van den Bosch, MAAJ
    Kemmeren, JM
    Algra, A
    Ossewaarde, JM
    Visseren, FLJ
    van Loon, AM
    van der Graaf, Y
    [J]. ATHEROSCLEROSIS, 2002, 163 (01) : 149 - 156
  • [6] Bloom DE, 2013, IZA DISCUSSION PAPER
  • [7] CYTOMEGALOVIRUS-INFECTION WITH PERFUSION DEFECTS ON THE LUNG-SCAN
    BOERS, M
    HAAK, A
    [J]. INFECTION, 1984, 12 (04) : 265 - 267
  • [8] Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
    Bowden, Jack
    Smith, George Davey
    Burgess, Stephen
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (02) : 512 - 525
  • [9] Broadbent Jim R, 2020, Wellcome Open Res, V5, P252, DOI 10.12688/wellcomeopenres.16374.1
  • [10] Harnessing Gut Microbes for Mental Health: Getting From Here to There
    Bruce-Keller, Annadora J.
    Salbaum, J. Michael
    Berthoud, Hans-Rudolf
    [J]. BIOLOGICAL PSYCHIATRY, 2018, 83 (03) : 214 - 223